Related Experiment Video
Updated: May 25, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
345
Transcranial Pulsed Current Stimulation (tPCS) in Parkinson's Disease: A Pilot Trial
Dinkar Kulshreshtha1,2, Olivia Samotus3, Yokesh Tamilselvam4
1Movement Disorder Centre, London Health Sciences Centre, Western University, London, ON, Canada.
Summary
Transcranial pulsed current stimulation (tPCS) showed mild improvements in electrophysiological measures and was well-tolerated by Parkinson's disease (PD) patients. Further research may explore tPCS as an alternative therapy for PD.
Area of Science:
- Neuroscience
- Neurology
- Biomedical Engineering
Background:
- Noninvasive stimulation techniques offer a promising therapeutic approach for Parkinson's disease (PD) due to their ease of administration and minimal side effects.
- Investigated the clinical, electrophysiological, and side effect profiles of transcranial pulsed current stimulation (tPCS) in PD patients.
Purpose of the Study:
- To evaluate the efficacy and safety of tPCS as a potential therapeutic intervention for Parkinson's disease.
- To assess the impact of tPCS on clinical symptoms, motor function, and electrophysiological parameters in PD patients.
Main Methods:
- Ten PD patients underwent monthly assessments in a levodopa-off state.
- Interventions included active tPCS, sham stimulation, and levodopa response assessment over three visits.
- Clinical scores, bradykinesia, gait, tremor, and quantitative electroencephalography (EEG) were analyzed pre- and post-intervention.
Main Results:
- Levodopa demonstrated significant clinical improvement compared to active and sham tPCS.
- Active tPCS showed a non-significant improvement in tremor severity and stride velocity variability compared to sham.
- Significant improvements in reaction time (KINARM) and a transitory increase in EEG alpha bandpower were observed post-tPCS.
Conclusions:
- tPCS was well-tolerated with minimal side effects in PD patients.
- The study suggests tPCS may offer mild improvements in electrophysiological parameters.
- tPCS presents a potential alternative therapeutic option for managing Parkinson's disease.

